Showing 1,447 news articles about Pharmaceutical industry

Filters Content type: Editors' picks Topic: Pharmaceutical industry

News and information on drug companies, the cost of therapies, patent protections and generic medicines.

Pharmaceutical industry

J&J, U.S. Sue Teva to Block Generic Version of Prezista HIV Drug

Editor's pick
Bloomberg
19 March 2011
Epidemiology

UNAIDS, activists urge countries to get clever with TRIPS

Editor's pick
IRIN Plus News
17 March 2011
New & experimental hepatitis C treatment

Who will win the hepatitis C market?

Editor's pick
Seeking Alpha
15 March 2011
New & experimental HIV treatments

HIV drug firm Koronis Pharmaceuticals eyes London listing

Editor's pick
Daily Telegraph
14 March 2011
New & experimental HIV treatments

Gilead's High Bar for AIDS Drugs Means New Development Withers

Editor's pick
San Francisco Chronicle
14 March 2011
Clinical trials

Meta-analyses cagey about funding sources/affiliations, review finds

Editor's pick
Pharma Times
11 March 2011
HIV treatment for children & young people

Tentative approval for abacavir sulfate scored tablets for oral suspension, 60 mg

Editor's pick
PharmaLive
10 March 2011
Government, leadership & policy

Canada: Commons passes bill to send generic drugs to developing countries

Editor's pick
Montreal Gazette
10 March 2011
Pharmaceutical industry

HIV/AIDS Update - Tentative approval for Lamivudine and Tenofovir DF Fixed Dose Combination Tablets, 300 mg/300 mg

Editor's pick
PharmaLive
10 March 2011
HIV treatment

Glaxo Seeks $1.5 Billion in AIDS Drug Trial Against Abbott

Editor's pick
Bloomberg
1 March 2011
PrEP

Gilead's $12000-a-Year HIV Prevention Pill Fails to Win Physician Support

Editor's pick
28 February 2011
PrEP

Gilead's $12000-a-Year HIV Prevention Pill Fails to Win Physician Support

Editor's pick
Bloomberg
28 February 2011
PrEP

Concept paper on medicines to prevent HIV infection released for public consultation

Editor's pick
European Medicines Agency
27 February 2011
Epidemiology

Other routes to HIV drug assistance

Editor's pick
Los Angeles Times
26 February 2011
Pharmaceutical industry

Drug R&D costs are less than estimated – so why the high prices?

Editor's pick
The Globe & Mail (Toronto)
25 February 2011
Pharmaceutical industry

Germany: Major fraud suspected with HIV drugs

Editor's pick
The Local
25 February 2011
Pharmaceutical industry

German authorities probe HIV drug fraud

Editor's pick
Bloomberg Business Week
24 February 2011
Pharmaceutical industry

Gilead Pursues Cancer, Inflammation as Next Step To Diversify Beyond HIV

Editor's pick
Xconomy
23 February 2011
Clinical trials

AIDS Activists Call on Public to Support New FDA HIV Drug Approval Policy

Editor's pick
Poz
23 February 2011
New & experimental HIV treatments

Chimerix Pockets $45M to Further Antiviral Development

Editor's pick
Genetic Engineering News
14 February 2011
New & experimental HIV treatments

Gilead refiles for approval of HIV drug

Editor's pick
San Francisco Business Times
11 February 2011
New & experimental HIV treatments

Sangamo's Bet Against AIDS: Gene Therapy

Editor's pick
Bloomberg Business Week
10 February 2011
Pharmaceutical industry

Big Pharma shows willingness to pool HIV/Aids drug patents

Editor's pick
The Guardian
10 February 2011
Pharmaceutical industry

Idenix drops after FDA loosens one hold but slaps on another

Editor's pick
Fierce Biotech
10 February 2011